CELL ACTIVATION METHOD AND CELL PRODUCTION METHOD AND MEDICINAL COMPOSITION USING THE SAME
A medicinal composition containing a CD3 agonist stimulating (main stimulation) cytotoxic T lymphocytes or cytotoxic T lymphocyte precursors (hereinafter called precursor cells) mediated by CD3 molecules in the cytotoxic T lymphocytes or the precursor cells, and a CD52 agonist stimulating (co-stimul...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English French Japanese |
Published |
14.04.2005
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A medicinal composition containing a CD3 agonist stimulating (main stimulation) cytotoxic T lymphocytes or cytotoxic T lymphocyte precursors (hereinafter called precursor cells) mediated by CD3 molecules in the cytotoxic T lymphocytes or the precursor cells, and a CD52 agonist stimulating (co-stimulation) cytotoxic T lymphocytes or precursor cells mediated by CD52 molecules in the cytotoxic T lymphocytes or the precursor cells.
L'invention concerne une composition médicinale contenant un agoniste de CD3 stimulant (stimulation principale) les lymphocytes T cytotoxiques ou les précurseurs de lymphocytes T cytotoxiques (appelés ci-dessous cellules précurseurs) médiés par les molécules CD3 dans les lymphocytes T cytotoxiques ou les cellules précurseurs, ainsi qu'un agoniste de CD52 stimulant (co-stimulation) les lymphocytes T cytotoxiques ou les cellules précurseurs médiés par les molécules CD52 dans les lymphocytes T cytotoxiques ou les cellules précurseurs. |
---|---|
Bibliography: | Application Number: WO2004JP14170 |